Скачать или смотреть Workshop: Identifying Pitfalls within Gene Therapy Development and How to Overcome Them

This session will cover recent advancements in gene therapy with insights from gene therapy developers and CDMOs on common pitfalls and how to avoid and overcome them. Join this interactive session to learn about their strategies and lessons learned. Topics discussed will range from insourcing vs. outsourcing, building reliable and scalable processes, and their vision for the future of gene therapy.

Chair:
Amy Butler, Ph.D., VP and GM Cell Biology, Thermo Fisher Scientific

Speakers:
Timothy Miller, Ph.D., Co-Founder, President, and Chief Scientific Officer, Abeona Therapeutics
Nicole O’Brien, Ph.D., Senior Director, Technical Program Design, Viral Vector Services, Thermo Fisher Scientific
Robert Pietrusko, Pharm.D., SVP, Regulatory Affairs and Quality Assurance, Voyager Therapeutics
Jeff Walsh, Chief Strategy Officer, bluebird bio
Ran Zheng, Chief Technical Officer, Orchard Therapeutics